Abstract
Antipsychotic-induced extrapyramidal symptoms (AIEPSs) are commonly recognized side effects of typical 1st generation antipsychotics, and considerable variability is seen in the susceptibility of individual patients to AIEPSs. Regulator of G-protein signaling 2 (RGS2) proteins regulate intracellular signaling and second messenger activation of molecules including dopamine, serotonin, and acetylcholine receptors, all of which appear to be involved in the pathophysiology of AIEPSs. Previous studies have shown an association between AIEPSs in schizophrenia and RGS2, especially the minor G allele of single nucleotide polymorphism (SNP) rs4606 (+2971C>G) in RGS2, and have suggested a possible protective effect by the G allele on AIEPSs. In this study, we investigated whether the rs4606 SNP in RGS2 alone also showed an effect on AIEPSs by utilizing the Drug-Induced Extrapyramidal Symptom Scale (DIEPSS) in 103 Japanese patients with schizophrenia. In the assumed G allele recessive model, sialorrhea and total Parkinsonism scores were significantly higher in subjects with the GG genotype than in subjects with other genotypes. Other clinical variables were not significantly different among the various genotype groups. Controlling for cli...Continue Reading
References
Jul 1, 1976·Archives of General Psychiatry·J M Davis
Apr 1, 1997·Biological Psychiatry·C H ChenK J Hsiao
Oct 8, 1997·Journal of Clinical Psychopharmacology·P V TranG D Tollefson
Aug 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M P CaligiuriD V Jeste
Aug 10, 1999·Journal of Clinical Psychopharmacology·M P CaligiuriD V Jeste
Mar 30, 2000·The American Journal of Psychiatry·S KapurS Houle
Dec 1, 2000·The American Journal of Psychiatry·K RickelsM Rynn
Apr 24, 2001·Molecular Psychiatry·V S BasileJ L Kennedy
Jan 23, 2002·American Journal of Medical Genetics·H HoriJ Nakamura
Feb 13, 2002·Molecular Psychiatry·R H Segman, B Lerer
Sep 12, 2002·Schizophrenia Research·Toshiya InadaSadanori Miura
Sep 12, 2002·Pharmacological Reviews·Susanne Hollinger, John R Hepler
Apr 20, 2004·Cellular Signalling·Afshin GhavamiKathleen H Young
Sep 11, 2004·Journal of Psychopharmacology·Gavin P Reynolds
Oct 8, 2004·Schizophrenia Research·Aygun ErtugrulHerbert Y Meltzer
Apr 29, 2005·The International Journal of Neuropsychopharmacology·Bernard LererFabio Macciardi
Jan 18, 2007·European Journal of Clinical Pharmacology·Cüneyt GüzeyOlav Spigset
Jun 15, 2007·Pharmacogenetics and Genomics·Lior GreenbaumBernard Lerer
Mar 19, 2008·The Pharmacogenomics Journal·L GreenbaumB Lerer
Oct 7, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tohru OhnumaHeii Arai
Jan 22, 2009·Human Psychopharmacology·Asmar F Al HadithyPeter N van Harten
Citations
Sep 29, 2011·Psychopharmacology·Lior GreenbaumBernard Lerer
Dec 17, 2014·Molekuliarnaia biologiia·A E GareevaE K Khusnutdinova
Nov 8, 2011·CNS Drugs·Maria J ArranzJanet C Munro
Oct 24, 2014·Pharmacogenomics·Hao TangGavin P Reynolds
Oct 13, 2011·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Antonio DragoAlessandro Serretti
Mar 10, 2015·Frontiers in Neurology·Lior Greenbaum, Bernard Lerer
Jan 30, 2013·International Journal of Psychiatry in Medicine·Tohru OhnumaHeii Arai
Oct 5, 2016·Translational Psychiatry·A HadarD Gurwitz
Mar 26, 2011·Genes & Nutrition·Estelle WolffDenis Lairon
Nov 26, 2011·Expert Review of Clinical Pharmacology·Maria J Arranz, Janet C Munro
Apr 24, 2013·Journal of Clinical Psychopharmacology·Wilma KnolToine C G Egberts
Jun 3, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Eva J BrandlDaniel J Müller
Sep 26, 2020·Molecular Pharmacology·Harrison J McNabbBenita Sjögren
Oct 19, 2021·Frontiers in Aging Neuroscience·Elena MilanesiAntonio Cuadrado